tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

QTTB Stock Latest News

Q32 Bio price target lowered to $22 from $64 at BMO Capital
The FlyQ32 Bio price target lowered to $22 from $64 at BMO Capital
9d ago
QTTB
Q32 Bio downgraded to Neutral at Guggenheim after failure in atopic dermatitis
PremiumThe Fly
Q32 Bio downgraded to Neutral at Guggenheim after failure in atopic dermatitis
9d ago
QTTB
Q32 Bio downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Q32 Bio downgraded to Neutral from Buy at Guggenheim
10d ago
QTTB
Q32 Bio price target lowered to $20 from $80 at Oppenheimer
PremiumThe Fly
Q32 Bio price target lowered to $20 from $80 at Oppenheimer
10d ago
QTTB
Q32 Bio Announces Mixed Results in Clinical Trials
PremiumCompany Announcements
Q32 Bio Announces Mixed Results in Clinical Trials
10d ago
8K
QTTB
Q32 Bio price target lowered to $20 from $85 at Piper Sandler
PremiumThe FlyQ32 Bio price target lowered to $20 from $85 at Piper Sandler
10d ago
QTTB
Q32 Bio downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Q32 Bio downgraded to Market Perform from Outperform at Leerink
10d ago
QTTB
Q32 Bio downgraded to Outperform from Strong Buy at Raymond James
Premium
The Fly
Q32 Bio downgraded to Outperform from Strong Buy at Raymond James
10d ago
QTTB
Q32 Bio downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
Q32 Bio downgraded to Equal Weight from Overweight at Wells Fargo
11d ago
QTTB
Q32 Bio reports results from SIGNAL-AA Phase 2a clinical trial
PremiumThe Fly
Q32 Bio reports results from SIGNAL-AA Phase 2a clinical trial
11d ago
QTTB
Q32 Bio initiated with an Outperform at BMO Capital
PremiumThe Fly
Q32 Bio initiated with an Outperform at BMO Capital
16d ago
QTTB
Q32 Bio Advances Clinical Trials Amidst Financial Challenges
PremiumCompany Announcements
Q32 Bio Advances Clinical Trials Amidst Financial Challenges
1M ago
QTTB
Q32 Bio Inc Grapples with Internal Control Challenges Amid Compliance Costs
PremiumCompany AnnouncementsQ32 Bio Inc Grapples with Internal Control Challenges Amid Compliance Costs
1M ago
QTTB
Q32 Bio reports Q3 EPS ($1.46), consensus ($1.40)
Premium
The Fly
Q32 Bio reports Q3 EPS ($1.46), consensus ($1.40)
1M ago
QTTB
Q32 Bio initiated with a Strong Buy at Raymond James
Premium
The Fly
Q32 Bio initiated with a Strong Buy at Raymond James
2M ago
QTTB
Q32 Bio Inc. Patent Woes: Navigating the Perilous Waters of Intellectual Property Disputes
PremiumCompany Announcements
Q32 Bio Inc. Patent Woes: Navigating the Perilous Waters of Intellectual Property Disputes
3M ago
QTTB
Q32 Bio initiated with an Overweight at Wells Fargo
PremiumThe Fly
Q32 Bio initiated with an Overweight at Wells Fargo
3M ago
QTTB
Q32 Bio reports Q2 EPS ($1.42), consensus ($1.04)
PremiumThe Fly
Q32 Bio reports Q2 EPS ($1.42), consensus ($1.04)
5M ago
QTTB
Q32 Bio Advances in Atopic Dermatitis Treatment Trial
PremiumCompany Announcements
Q32 Bio Advances in Atopic Dermatitis Treatment Trial
6M ago
8K
QTTB
Q32 Bio completes enrollment in SIGNAL-AD clinical trial
PremiumThe FlyQ32 Bio completes enrollment in SIGNAL-AD clinical trial
6M ago
QTTB
Q32 Bio to join Russell 3000 Index
Premium
The Fly
Q32 Bio to join Russell 3000 Index
6M ago
QTTB
Verve Therapeutics appoints Nia Tatsis, Jodie Morrison to board
Premium
The Fly
Verve Therapeutics appoints Nia Tatsis, Jodie Morrison to board
6M ago
QTTB
VERV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >